中药多糖结肠靶向递药治疗溃疡性结肠炎的研究进展

Research Progress on Colon-Targeted Delivery of Traditional Chinese Medicine Polysaccharides for the Treatment of Ulcerative Colitis

  • 摘要: 溃疡性结肠炎(Ulcerative Colitis, UC)是一种慢性炎症性肠病,目前临床上针对UC的治疗手段仍存在靶向性不足、易引发全身性副作用等问题。中药多糖具有独特的抗炎、抗氧化及肠道菌群调节作用,在UC治疗中展现出良好的潜力,但其口服递送受限于胃酸降解、酶解失活及病灶蓄积效率低等瓶颈问题。本文解析了具有UC防治潜力的中药多糖及其作用机制,并重点综述了当前用于UC治疗的中药多糖结肠靶向递药系统的研究进展,突出了其在提升药物稳定性、结肠特异释放性和治疗效果方面的创新价值。同时指出当前研究存在多糖结构异质性大、临床转化不足等挑战,并对未来构效关系解析、多重响应系统开发及个体化治疗等方向作出展望,以期为新型UC靶向治疗策略的开发提供理论参考。

     

    Abstract: Ulcerative Colitis (UC) is a chronic inflammatory bowel disease. At present, the clinical treatment methods for UC still have problems such as insufficient targeting and easy to cause systemic side effects. Modern research shows that traditional Chinese medicine polysaccharides have unique anti-inflammatory, antioxidant and intestinal flora regulatory effects, and have shown good potential in the treatment of UC. However, their oral delivery is limited by bottleneck problems such as gastric acid degradation, enzymatic inactivation and low efficiency of lesion accumulation. This article analyzes the traditional Chinese medicine polysaccharides with preventive and therapeutic effects on UC and their mechanisms of action, and focuses on reviewing the current research progress of the traditional Chinese medicine polysaccharide colon-targeted drug delivery system used for UC treatment, highlighting its innovative value in enhancing drug stability, colon-specific release, and therapeutic effects. At the same time, it is pointed out that the current research faces challenges such as large heterogeneity of polysaccharide structure and insufficient clinical transformation. Prospects are also made for future directions such as structure-activity relationship analysis, development of multiple response systems, and individualized treatment, with the aim of providing theoretical references for the development of new targeted treatment strategies for UC.

     

/

返回文章
返回